| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |